Research paperConversion of irinotecan (CPT-11) to its active metabolite, 7-ethyl-10-hydroxycamptothecin (SN-38), by Human Liver Carboxylesterase☆
References (15)
- et al.
Molecular, cellular, and clinical aspects of the pharmacology of 20(S)camptothecin and its derivatives
Pharmacol Ther
(1995) - et al.
Purification and characterization of two human liver carboxylesterases
Int J Biochem
(1989) - et al.
Reversed-phase high-performance liquid Chromatographic method for the simultaneous quantitation of the carboxylate and lactone forms of the camptothecin derivative irinotecan, CPT-11, and its metabolite SN-38 in plasma
J Chromatogr B Biomed Appl
(1994) - et al.
Human liver carboxylesterase. Purification and molecular properties
Arch Biochem Biophys
(1974) - et al.
A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues
J Pharm Sci
(1992) - et al.
Synthesis and antitumor activity of 20(S)-camptothecin derivatives: Carbamate-linked, water-soluble derivatives of 7-ethyl-10-hydroxycamptothecin
Chem Pharm Bull (Tokyo)
(1991) - et al.
The current status of camptothecin analogues as antitumor agents
J Natl Cancer Inst
(1993)
There are more references available in the full text version of this article.
Cited by (236)
Macrophage membrane-coated SN-38-encapsulated liposomes for efficient treatment of colorectal cancer
2024, Journal of Drug Delivery Science and TechnologyRole of MRPs transporters in pharmacokinetics and intestinal toxicity of irinotecan
2023, Food and Chemical ToxicologyCarbon dots conjugated to SN38 for improved colorectal anticancer therapy
2022, Materials Today BioAssessment of Drug–drug Interaction and Optimization in Capecitabine and Irinotecan Combination Regimen using a Physiologically Based Pharmacokinetic Model
2022, Journal of Pharmaceutical SciencesCarboxylesterase inhibitors from clinically available medicines and their impact on drug metabolism
2021, Chemico-Biological InteractionsClick 1,2,3-triazoles in drug discovery and development: From the flask to the clinic?
2021, Advances in Heterocyclic Chemistry
- ☆
This research was funded by a grant from the Australian National Health and Medical Research Council (NHMRC920298). L.P.R. is the recipient of an NHMRC/INSERM Exchange Fellowship.
Copyright © 1996 Published by Elsevier Inc.